120 related articles for article (PubMed ID: 28619846)
21. Targeting chemokines for acute lymphoblastic leukemia therapy.
Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L
J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810
[TBL] [Abstract][Full Text] [Related]
22. Pediatric acute lymphoblastic leukemia-Conquering the CNS across the choroid plexus.
März M; Meyer S; Erb U; Georgikou C; Horstmann MA; Hetjens S; Weiß C; Fallier-Becker P; Vandenhaute E; Ishikawa H; Schroten H; Dürken M; Karremann M
Leuk Res; 2018 Aug; 71():47-54. PubMed ID: 30005184
[TBL] [Abstract][Full Text] [Related]
23. CXCR4/CXCL12 signaling impacts enamel progenitor cell proliferation and motility in the dental stem cell niche.
Yokohama-Tamaki T; Otsu K; Harada H; Shibata S; Obara N; Irie K; Taniguchi A; Nagasawa T; Aoki K; Caliari SR; Weisgerber DW; Harley BA
Cell Tissue Res; 2015 Dec; 362(3):633-42. PubMed ID: 26246398
[TBL] [Abstract][Full Text] [Related]
24. CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.
de Lourdes Perim A; Amarante MK; Guembarovski RL; de Oliveira CE; Watanabe MA
Cell Mol Life Sci; 2015 May; 72(9):1715-23. PubMed ID: 25572297
[TBL] [Abstract][Full Text] [Related]
25. CXCL12-CXCR4 Axis Is Required for Contact-Mediated Human B Lymphoid and Plasmacytoid Dendritic Cell Differentiation but Not T Lymphoid Generation.
Minami H; Nagaharu K; Nakamori Y; Ohishi K; Shimojo N; Kageyama Y; Matsumoto T; Sugimoto Y; Tawara I; Masuya M; Miwa H; Katayama N
J Immunol; 2017 Oct; 199(7):2343-2355. PubMed ID: 28842468
[TBL] [Abstract][Full Text] [Related]
26. Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.
Parameswaran R; Yu M; Lim M; Groffen J; Heisterkamp N
Leukemia; 2011 Aug; 25(8):1314-23. PubMed ID: 21483439
[TBL] [Abstract][Full Text] [Related]
27. Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1α (CXCL12).
Freret M; Gouel F; Buquet C; Legrand E; Vannier JP; Vasse M; Dubus I
Leuk Res; 2011 Jul; 35(7):971-3. PubMed ID: 21458858
[TBL] [Abstract][Full Text] [Related]
28. CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis.
Braun M; Qorraj M; Büttner M; Klein FA; Saul D; Aigner M; Huber W; Mackensen A; Jitschin R; Mougiakakos D
Leukemia; 2016 Aug; 30(8):1788-92. PubMed ID: 26952837
[No Abstract] [Full Text] [Related]
29. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Tavor S; Petit I
Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
[TBL] [Abstract][Full Text] [Related]
30. T-ALL: Home Is where the CXCL12 Is.
de Bock CE; Cools J
Cancer Cell; 2015 Jun; 27(6):745-6. PubMed ID: 26058071
[TBL] [Abstract][Full Text] [Related]
31. Effect of co‑culture with amniotic epithelial cells on the biological characteristics of amniotic mesenchymal stem cells.
Ran LJ; Zeng Y; Wang SC; Zhang DS; Hong M; Li SY; Dong J; Shi MX
Mol Med Rep; 2018 Jul; 18(1):723-732. PubMed ID: 29845205
[TBL] [Abstract][Full Text] [Related]
32. Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation.
Mowafi F; Cagigi A; Matskova L; Björk O; Chiodi F; Nilsson A
Pediatr Blood Cancer; 2008 Apr; 50(4):812-7. PubMed ID: 17914737
[TBL] [Abstract][Full Text] [Related]
33. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
[TBL] [Abstract][Full Text] [Related]
34. ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy.
Chen Z; Teo AE; McCarty N
Clin Cancer Res; 2016 Jan; 22(1):187-99. PubMed ID: 26350264
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXCL12 and CXCR4 in human endometrium; effects of CXCL12 on MMP production by human endometrial cells.
Laird SM; Widdowson R; El-Sheikhi M; Hall AJ; Li TC
Hum Reprod; 2011 May; 26(5):1144-52. PubMed ID: 21357602
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
[TBL] [Abstract][Full Text] [Related]
37. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
38. CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1.
Marquez-Curtis LA; Gul-Uludag H; Xu P; Chen J; Janowska-Wieczorek A
Cytotherapy; 2013 Jul; 15(7):840-9. PubMed ID: 23623275
[TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of stromal cell-derived factor-1alpha and its receptor CXCR4 in human dental pulp cells].
Gong QM; Ling JQ; Jiang HW; Du Y; Yang F
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):146-50. PubMed ID: 18788547
[TBL] [Abstract][Full Text] [Related]
40. [Expression of SDF-1alpha and its receptor CXCR4 in acute leukemias and their relationship with extramedullary infiltration].
Liu ZR; Sun H; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):1-5. PubMed ID: 16584580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
